Furthermore, it decreases the size and growth of the ovarian tumor and speeds up the inhibition of the STAT3 and NF‐KB signals as well as the activation of the nuclear factor erythroid 2/heme oxygenase1 (Nrf2/HO‐1) pathway. Here, HMOX1 is linked to ovarian neoplasm.